Nightstar Therapeutics Sponsored ADR - 48 Year Dividend Yield History | NITE

Historical dividend payout and yield for Nightstar Therapeutics Sponsored ADR (NITE) since 1971. The current TTM dividend payout for Nightstar Therapeutics Sponsored ADR (NITE) as of February 15, 2019 is $0.00. The current dividend yield for Nightstar Therapeutics Sponsored ADR as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.424B $0.000B
Nightstar Therapeutics Limited is a clinical-stage gene therapy company. It focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy. The company operates primarily in North America and Europe. Nightstar Therapeutics Limited is based in LONDON, United Kingdom.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76